// App-Quantinova.ai

: Extracellular matrix biomarkers predict change in lung function in idiopathic pulmonary fibrosis

Researchers

Presenter

  • Henrik Jessen

Principal Investigators

  • Nils Hoyer

  • Sarah Rønnow

  • Morten Karsdal

  • Diana Leeming

  • Jannie Sand

  • Saher Shaker

Medical Centers

  • Biomarkers and Research, Nordic Bioscience, Herlev, Denmark,

Locations

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N-terminal type III collagen propeptide

Drug/Treatment

  • Pirfenidone

  • Nintedanib

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved